Ford is recalling 272,645 vehicles in the U.S. due to a loss of park function, causing the vehicle to roll away and ...

A new study identifies molecular factors that promote small vessel disease—and an active drug that can restore impaired ...

The recall includes certain 2016-2020 Honda Acura ILX vehicles, according to the National Highway Traffic Safety ...

"She could not put weight on one of her legs and then she had these contraptions on her body," said Kemal about a rod to keep ...

Today’s hearing aids have life-saving benefits that go beyond helping you hear. And they’re more discreet and advanced than ever.

Based Probiotic Category Ahead of 2026 Weight-Loss Season - Ingredient Research, Regulatory Context, and Evidence Gaps ...

Step aside, semaglutide—retatrutide is showing the most impressive weight loss results of any obesity drug to date.

Researchers from Miguel Hernández University of Elche (UMH) in Spain have identified an effective strategy to reduce ...

Today’s AI tools are embedded directly in the flow of work and can increasingly perform significant portions of that work.

Lilly is investigating the triple G agonist retatrutide in seven other Phase III trials, which are due to read out in 2026.

Eli Lilly (LLY) stock gains as the company's next-generation weight loss candidate, retatrutide succeeds in a Phase 3 trial. Read more here.

Most people stick to bananas, berries, apples and grapes, but many other fruits offer benefits for heart health, weight loss ...